Acute hepatitis C linked to chemsex and slamsex in MSM study. Low clearance and care gaps found. Read more on implications ...
FDA approves ensitrelvir for COVID-19 postexposure prophylaxis following phase 3 data showing efficacy against Omicron symptoms. The FDA recently approved ensitrelvir (Xocova; Shionogi), an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results